Status:
COMPLETED
Investigating Patient Satisfaction With Oral Anti-Cancer Treatment
Lead Sponsor:
KU Leuven
Collaborating Sponsors:
Flemish League Against Cancer
Pfizer
Conditions:
Clear Cell Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Prospective non-interventional non-controlled multicenter observational study to evaluate aspects of pharmaceutical care in patients with advanced renal cell carcinoma treated with an oral anti-cancer...
Eligibility Criteria
Inclusion
- Patients who are 18 years or older, and who can be contacted by phone and/or e-mail are eligible for the study
Exclusion
- Patients who are not able to understand Dutch or French will be excluded from the study
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT02247583
Start Date
February 1 2011
End Date
July 1 2013
Last Update
September 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Katholieke Universiteit Leuven - Klinische Farmacologie en Farmacotherapie
Leuven, Belgium, 3000